Clinical factors associated with the no/slow-reflow phenomenon in patients with acute coronary syndrome

Aim. To determine the incidence of the no-reflow phenomenon in patients with acute coronary syndrome (ACS) undergoing primary percutaneous coronary intervention (PCI), and to study factors associated with its occurrence in the daily work of the City Clinical Hospital.Material and methods. Of the 209...

Full description

Bibliographic Details
Main Authors: E. V. Konstantinova, Yu. S. Ilin, A. A. Velikotskiy, N. A. Rakhimi, A. A. Bogdanova, A. V. Ploshchenkov
Format: Article
Language:English
Published: Столичная издательская компания 2024-03-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/2994
_version_ 1797232000706281472
author E. V. Konstantinova
Yu. S. Ilin
A. A. Velikotskiy
N. A. Rakhimi
A. A. Bogdanova
A. V. Ploshchenkov
author_facet E. V. Konstantinova
Yu. S. Ilin
A. A. Velikotskiy
N. A. Rakhimi
A. A. Bogdanova
A. V. Ploshchenkov
author_sort E. V. Konstantinova
collection DOAJ
description Aim. To determine the incidence of the no-reflow phenomenon in patients with acute coronary syndrome (ACS) undergoing primary percutaneous coronary intervention (PCI), and to study factors associated with its occurrence in the daily work of the City Clinical Hospital.Material and methods. Of the 2090 patients with ACS admitted to N. I. Pirogov City Clinical Hospital No.1 in the period from 01.01.2017 to 01.11.2022 there were 2 groups of patients with PCI: group 1 (n=59) included patients with initial antegrade coronary blood flow TIMI 0 and final blood flow TIMI 0-2 (with the no/ slow-reflow phenomenon); Group 2 (n=149) included patients with initial coronary blood flow TIMI 0 and final antegrade coronary blood flow TIMI 3 (without the no/slow-reflow phenomenon).Results. The no-/slow-reflow phenomenon was observed in 2.8% of cases. Patients with no-/slow-reflow phenomenon more frequently had diabetes mellitus (42.4% vs. 22.8%, p=0.003), a history of stroke (12.1% vs. 3.4%, p=0.016), higher Killip class and "pain-to-balloon" time 7 [3; 16] vs. 4 [2.3; 8.25] hours, p=0.004. Binary logistic regression identified "pain-to-balloon" time as the most significant predictor of no-/slow-reflow phenomenon development [Odds Ratio (OR)=1.03; 95% CI: 0.95-0.996; p=0.02] and the proximal level of occlusion in infarct-related coronary artery. The incidence of in-hospital mortality was 6.1 times higher in the no-/slow-reflow group compared to the normal blood flow group [OR=6.102±0.433; 95% CI: 2.614-14.247; p<0.05].Conclusion. The development of the no-/slow-reflow phenomenon was observed in 2.8% of patients in clinical practice N. I. Pirogov City Clinical Hospital No.1. Its development was associated with an increase in the incidence of unfavorable outcome of the disease in the hospital. The total time of myocardial ischemia, the presence of diabetes mellitus, a history of stroke, and a higher Killip class of acute heart failure at admission were more often associated with the development of the no-/slow-reflow phenomenon. The proximal level of damage to the infarct-related artery and "pain-to-balloon" time were independent predictors of the no-/slowreflow phenomenon.
first_indexed 2024-04-24T15:53:19Z
format Article
id doaj.art-1ad4002effb9417b84ec1ec6313806a3
institution Directory Open Access Journal
issn 1819-6446
2225-3653
language English
last_indexed 2024-04-24T15:53:19Z
publishDate 2024-03-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj.art-1ad4002effb9417b84ec1ec6313806a32024-04-01T07:43:44ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532024-03-01201273410.20996/1819-6446-2024-29942181Clinical factors associated with the no/slow-reflow phenomenon in patients with acute coronary syndromeE. V. Konstantinova0Yu. S. Ilin1A. A. Velikotskiy2N. A. Rakhimi3A. A. Bogdanova4A. V. Ploshchenkov5N. I. Pirogov Russian National Research Medical University; N. I. Pirogov City Clinical Hospital No. 1N. I. Pirogov Russian National Research Medical UniversityN. I. Pirogov City Clinical Hospital No. 1N. I. Pirogov Russian National Research Medical UniversityN. I. Pirogov Russian National Research Medical University; N. I. Pirogov City Clinical Hospital No. 1N. I. Pirogov City Clinical Hospital No. 1Aim. To determine the incidence of the no-reflow phenomenon in patients with acute coronary syndrome (ACS) undergoing primary percutaneous coronary intervention (PCI), and to study factors associated with its occurrence in the daily work of the City Clinical Hospital.Material and methods. Of the 2090 patients with ACS admitted to N. I. Pirogov City Clinical Hospital No.1 in the period from 01.01.2017 to 01.11.2022 there were 2 groups of patients with PCI: group 1 (n=59) included patients with initial antegrade coronary blood flow TIMI 0 and final blood flow TIMI 0-2 (with the no/ slow-reflow phenomenon); Group 2 (n=149) included patients with initial coronary blood flow TIMI 0 and final antegrade coronary blood flow TIMI 3 (without the no/slow-reflow phenomenon).Results. The no-/slow-reflow phenomenon was observed in 2.8% of cases. Patients with no-/slow-reflow phenomenon more frequently had diabetes mellitus (42.4% vs. 22.8%, p=0.003), a history of stroke (12.1% vs. 3.4%, p=0.016), higher Killip class and "pain-to-balloon" time 7 [3; 16] vs. 4 [2.3; 8.25] hours, p=0.004. Binary logistic regression identified "pain-to-balloon" time as the most significant predictor of no-/slow-reflow phenomenon development [Odds Ratio (OR)=1.03; 95% CI: 0.95-0.996; p=0.02] and the proximal level of occlusion in infarct-related coronary artery. The incidence of in-hospital mortality was 6.1 times higher in the no-/slow-reflow group compared to the normal blood flow group [OR=6.102±0.433; 95% CI: 2.614-14.247; p<0.05].Conclusion. The development of the no-/slow-reflow phenomenon was observed in 2.8% of patients in clinical practice N. I. Pirogov City Clinical Hospital No.1. Its development was associated with an increase in the incidence of unfavorable outcome of the disease in the hospital. The total time of myocardial ischemia, the presence of diabetes mellitus, a history of stroke, and a higher Killip class of acute heart failure at admission were more often associated with the development of the no-/slow-reflow phenomenon. The proximal level of damage to the infarct-related artery and "pain-to-balloon" time were independent predictors of the no-/slowreflow phenomenon.https://www.rpcardio.online/jour/article/view/2994no-reflow phenomenonacute coronary syndromerisk factorsdiabetes mellitusin-hospital outcomespercutaneous coronary interventionmyocardial ischemia time
spellingShingle E. V. Konstantinova
Yu. S. Ilin
A. A. Velikotskiy
N. A. Rakhimi
A. A. Bogdanova
A. V. Ploshchenkov
Clinical factors associated with the no/slow-reflow phenomenon in patients with acute coronary syndrome
Рациональная фармакотерапия в кардиологии
no-reflow phenomenon
acute coronary syndrome
risk factors
diabetes mellitus
in-hospital outcomes
percutaneous coronary intervention
myocardial ischemia time
title Clinical factors associated with the no/slow-reflow phenomenon in patients with acute coronary syndrome
title_full Clinical factors associated with the no/slow-reflow phenomenon in patients with acute coronary syndrome
title_fullStr Clinical factors associated with the no/slow-reflow phenomenon in patients with acute coronary syndrome
title_full_unstemmed Clinical factors associated with the no/slow-reflow phenomenon in patients with acute coronary syndrome
title_short Clinical factors associated with the no/slow-reflow phenomenon in patients with acute coronary syndrome
title_sort clinical factors associated with the no slow reflow phenomenon in patients with acute coronary syndrome
topic no-reflow phenomenon
acute coronary syndrome
risk factors
diabetes mellitus
in-hospital outcomes
percutaneous coronary intervention
myocardial ischemia time
url https://www.rpcardio.online/jour/article/view/2994
work_keys_str_mv AT evkonstantinova clinicalfactorsassociatedwiththenoslowreflowphenomenoninpatientswithacutecoronarysyndrome
AT yusilin clinicalfactorsassociatedwiththenoslowreflowphenomenoninpatientswithacutecoronarysyndrome
AT aavelikotskiy clinicalfactorsassociatedwiththenoslowreflowphenomenoninpatientswithacutecoronarysyndrome
AT narakhimi clinicalfactorsassociatedwiththenoslowreflowphenomenoninpatientswithacutecoronarysyndrome
AT aabogdanova clinicalfactorsassociatedwiththenoslowreflowphenomenoninpatientswithacutecoronarysyndrome
AT avploshchenkov clinicalfactorsassociatedwiththenoslowreflowphenomenoninpatientswithacutecoronarysyndrome